Published in Bull World Health Organ on January 01, 1982
Q fever. Clin Microbiol Rev (1999) 11.32
Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev (1983) 3.76
Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun (1986) 1.47
Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. Int J Microbiol (2011) 1.33
Cloning and porin activity of the major outer membrane protein P1 from Coxiella burnetii. Infect Immun (2002) 0.98
Genetics of Coxiella burnetii: on the path of specialization. Future Microbiol (2011) 0.78
THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE. J Immunol (1964) 1.87
Safety test for Q fever vaccine. J Bacteriol (1960) 1.52
Lesions in guinea pigs infected with Coxiella burnetii strain M-44. J Infect Dis (1977) 1.09
From the Center for Disease Control: Q fever in the United States, 1948--1977. J Infect Dis (1979) 1.07
Immunization in man with a soluble Q fever vaccine. Arch Roum Pathol Exp Microbiol (1973) 0.97
REPORT OF A FIELD STUDY WITH Q FEVER VACCINE. Am J Hyg (1964) 0.94
Suitability of the microagglutination test for detection of post-infection and post-vaccination Q fever antibodies in human sera. Acta Virol (1981) 0.93
Biological properties of the M-44 strain of Coxiella burneti. J Infect Dis (1976) 0.93
[Result of the mass immunization of the human population with the M-44 vaccine against Q fever. I. Subcutaneous method of immunization]. Vopr Virusol (1966) 0.91
Q-fever soluble vaccine effects in Coxiella burneti sensitized humans. Zentralbl Bakteriol Orig A (1977) 0.91
Development of Q-fever vaccines, 1937 to 1967. Med J Aust (1967) 0.89
Q fever in Kenya. Serological investigations in man and domestic animals. East Afr Med J (1976) 0.85
Improved method of preparing phase II Coxiella burneti antigen for the microagglutination test. Acta Virol (1970) 0.84
Rickettsiae and rickettsial diseases. Bull World Health Organ (1973) 0.84
Q fever in Colombia, S.A. A serological survey of human and bovine populations. Zentralbl Veterinarmed B (1977) 0.82
Sero-epidemiological evidence of Coxiella burnetii infection among selected human population in Calcutta. Indian J Med Res (1978) 0.80
Deoxyribonucleic Acid Heterogeneity Between Human and Murine Strains of Chlamydia trachomatis. Infect Immun (1970) 2.34
Different sugar compositions of lipopolysaccharides isolated from phase I and pure phase II cells of Coxiella burnetii. Infect Immun (1982) 1.51
Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide. Infect Immun (1986) 1.38
Induction of hyperreactivity to endotoxin in mice by Coxiella burnetii. Infect Immun (1984) 1.36
Study on the effect of cyclophosphamide on experimental rickettsial infection. Acta Virol (1971) 1.26
Phagocytosis of Coxiella burneti by macrophages. Acta Virol (1975) 1.25
A new plasmid (QpDV) common to Coxiella burnetii isolates associated with acute and chronic Q fever. FEMS Microbiol Lett (1995) 1.18
Electron microscopy of Coxiella burneti phase I and II. Acta Virol (1968) 1.18
Interferon-like inhibitor in mouse sera induced by rickettsiae. Acta Virol (1966) 1.15
Two strains of rickettsiae of Rocky Mountain spotted fever group recovered from Dermacentor marginatus ticks in Czechoslovakia. Results of preliminary serological identification. Acta Virol (1969) 1.12
Characterization of an endotoxic lipopolysaccharide from Coxiella burnetii. Acta Virol (1976) 1.11
Some biological properties of an endotoxic lipopolysaccharide from the typhus group rickettsiae. Acta Virol (1977) 1.10
Advances in rickettsial research. Curr Top Microbiol Immunol (1969) 1.08
3-C-branched aldoses in lipopolysaccharide of phase I Coxiella burnetii and their role as immunodominant factors. Eur J Biochem (1985) 1.04
Nature and linkage type of fatty acids present in lipopolysaccharides of phase I and II Coxiella burnetii. Arch Microbiol (1985) 1.02
Serological examination of human and animal sera from six countries of three continents for the presence of rickettsial antibodies. Eur J Epidemiol (1996) 1.02
Search for correlates of resistance to virulent challenge in mice immunized with Coxiella burnetii. Acta Virol (1977) 1.01
Study of the antigenic structure of Coxiella burneti. 8. Immunogenicity of phenol-extracted phase I antigenic component. Acta Virol (1970) 1.00
Deoxyribonucleic acid base composition of members of the typhus group of rickettsiae. Acta Virol (1972) 0.99
Influence of mild acid hydrolysis on the antigenic properties of phase I Coxiella burnetii. Acta Virol (1978) 0.99
A new method of preparing diagnostic Q fever antigen. Acta Virol (1972) 0.98
Study of the antigenic structure of Coxiella burneti. VII. Properties of phenol-extracted phase I antigenic component. Acta Virol (1970) 0.98
Isolation and characterization of deoxyribonucleic acid from Coxiella burneti. Acta Virol (1968) 0.97
Lipid A in Legionella pneumophila. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.97
Electron microscopy of ruthenium red-stained phase I and II Coxiella burneti. Acta Virol (1972) 0.95
Lipid A component of lipopolysaccharides from Coxiella burnetii. Acta Virol (1981) 0.95
Partial Reassociation Between the Deoxyribonucleic Acids of Neisseria lactamicus and Neisseria meningitidis. Infect Immun (1971) 0.95
New advances in the study of rickettsial antigens. Zentralbl Bakteriol Orig (1968) 0.95
Testing in various systems of the neutralizing capacity of Q fever immune sera. Acta Virol (1973) 0.95
Isolation of a lipopoly saccharide antigen from Rickettsia species. Acta Virol (1976) 0.94
Suitability of the microagglutination test for detection of post-infection and post-vaccination Q fever antibodies in human sera. Acta Virol (1981) 0.93
Serological cross-reactions of lipid A components of lipopolysaccharides isolated from Chlamydia psittaci and Coxiella burnetii. Acta Virol (1980) 0.93
Studies on the E strain of Rickettsia prowazeki. Bull World Health Organ (1973) 0.92
Coxiella burnetii antigens for detection of Q fever antibodies by ELISA in human sera. Acta Virol (1987) 0.92
Antigenic and immunogenic properties of recombinants from Salmonella typhimurium and Salmonella minnesota rough mutants expressing in their lipopolysaccharide a genus-specific chlamydial epitope. Infect Immun (1987) 0.92
Control of rickettsial diseases. Eur J Epidemiol (1991) 0.92
Comparison of virulence for guinea pigs and mice of different Coxiella burnetii phase I strains. Acta Virol (1993) 0.90
Synthesis of three 3-C-hydroxymethylpentoses with the D-ribo-, D-xylo- and L-lyxo-configurations. Identification of the latter with a monosaccharide isolated from phase I Coxiella burnetii lipopolysaccharide. Acta Chem Scand B (1986) 0.89
[An epidemic of Q-fever in a cotton-processing plant (author's transl)]. Cesk Epidemiol Mikrobiol Imunol (1982) 0.89
Clinical and serological analysis of a Q fever outbreak in western Slovakia with four-year follow-up. Eur J Clin Microbiol Infect Dis (1998) 0.88
Isolation of endotoxic lipopolysaccharide from phase II Coxiella burnetti. Acta Virol (1979) 0.88
[Enzootic abortion among ewes in the Roznava district]. Vet Med (Praha) (1978) 0.87
Role of structural variations of polysaccharide antigens in the pathogenicity of Gram-negative bacteria. Clin Microbiol Infect (2007) 0.87
Multiplication of rickettsiae in tick cells in vitro. Acta Virol (1968) 0.87
Interference between Coxiella burneti and cytopathic viruses in chick embryo cell cultures. II. An attempt to elucidate the mechanism of the interference. Acta Virol (1969) 0.86
Q fever in Bulgaria and Slovakia. Emerg Infect Dis (1999) 0.86
Q fever in Spain: acute and chronic cases, 1981-1985. Rev Infect Dis (1988) 0.86
Concerning the question of infraforms in Rickettsia prowazeki. Acta Virol (1972) 0.86
Immunogenicity of Coxiella burnetii whole cells and their outer membrane components. Acta Virol (1994) 0.85
Rickettsioses studies. 1. Natural foci of rickettsioses in the Armenian Soviet Socialist Republic. Bull World Health Organ (1976) 0.85
Interference between Coxiella burneti and cytopathic viruses in chick embryo cell cultures. I. Establishment of the interference. Acta Virol (1969) 0.85
Further investigations on the fine structure of coxiella burneti. Zentralbl Bakteriol Orig A (1972) 0.85
Improved method of preparing phase II Coxiella burneti antigen for the microagglutination test. Acta Virol (1970) 0.84
Differential effects of cyclophosphamide on Coxiella burnetii infection in mice. Acta Virol (1982) 0.84
First report of an infection with Rickettsia slovaca. Folia Parasitol (Praha) (1980) 0.84
Inhibition by Coxiella burnetii of ascites tumour formation in mice. Acta Virol (1979) 0.84
Rickettsiae and rickettsial diseases. Bull World Health Organ (1973) 0.84
Selection of chlortetracycline-resistant strain of Coxiella burnetii. Acta Virol (1975) 0.84
Evidence for the structural heterogeneity of the polysaccharide component of Coxiella burnetii strain Nine Mile lipopolysaccharide. Acta Virol (1991) 0.83
Erythrocyte-sensitizing substance from Rickettsia Canadia. Acta Virol (1975) 0.83
Characterization and protective effect of a 29 kDa protein isolated from Coxiella burnetii by detergent Empigen BB. Eur J Epidemiol (1994) 0.83
Rickettsial diseases and their serological diagnosis. Clin Lab (2000) 0.82
Induction of splenomegaly in mice by killed Coxiella burnetii cells. Acta Virol (1983) 0.82
Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging. FEMS Microbiol Lett (1993) 0.82
Suitability of various Coxiella burnetii antigen preparations for detection of serum antibodies by various tests. Acta Virol (1998) 0.82
Immunoblot analysis of antibody response in mice infected with Coxiella burnetii phase I. Acta Virol (1992) 0.82
Sensitization of mice to rickettsial toxin by Coxiella burnetii. Acta Virol (1984) 0.82
[Analysis of serum immunoglobulins in a patient with chronic Q-fever and endocarditis (author's transl)]. Bratisl Lek Listy (1977) 0.82